Drug shortages

Jul 16, 2018
AHA comments on the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Jul 12, 2018
Food and Drug Administration Commissioner Scott Gottlieb, M.D., today announced the formation of a drug shortages task force. “I’m charging the shortages task force to delve more deeply into the reasons why some shortages remain a persistent challenge,” Gottlieb said. “The charge to this new…
Jun 20, 2018
Shortages of intravenous saline and other fluids are beginning to improve, according to the Food and Drug Administration. “Baxter is now producing at significantly higher levels,” said Douglas Throckmorton, M.D., deputy director for regulatory programs at FDA’s Center for Drug Evaluation and…
Jun 19, 2018
A bipartisan group of 31 senators last week urged Food and Drug Administration Commissioner Scott Gottlieb, M.D., to convene the Drug Shortages Task Force created by the FDA Safety and Innovation Act of 2012, stakeholders and other relevant agencies to report on the root causes of drug shortages…
Jun 18, 2018
The Food and Drug Administration identified 39 new drug and biological product shortages in 2017, up from 26 in 2016, and 41 ongoing shortages from prior years, according to the agency’s latest annual report on the issue. “Although the number of new drug shortages has declined since 2011 as a…
Jun 12, 2018
The American Medical Association today adopted a policy declaring drug shortages an urgent public health crisis. As part of the policy, AMA will urge the Department of Health and Human Services and the Department of Homeland Security to examine drug shortages as a national security initiative, and…
May 4, 2018
May 4, 2018 RE: Controlled Substances Quotas [Docket No. DEA-480]
The undersigned groups thank the Drug Enforcement Administration (DEA) for the opportunity to comment on its proposed rule regarding controlled substances quotas. Although we support DEA’s efforts to combat diversion, we are concerned that the proposed rule is focused on diversion to the exclusion…
May 4, 2018
May 4, 2018 Re: Docket No. DEA-480, Controlled Substances Quotas; Notice of Proposed Rulemaking (Vol. 83, No. 76), April 19, 2018.
We concur with the DEA that setting quotas for the production of opioid medications can be an effective step in “preventing the accumulation of controlled substances in amounts exceeding legitimate need,” and therefore reduce the chance that these powerful medications will be diverted for non-…